Related Experiment Video
Updated: Jun 12, 2026

08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
Temporal retinal thickness in eyes with glaucomatous visual field defects using optical coherence tomography
Ramanjit Sihota1, Prashant Naithani, Parul Sony
1Dr R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Journal of Glaucoma
|June 4, 2010
Summary
Optical coherence tomography 3 (OCT-3) revealed significant differences in superior-to-inferior retinal thickness (S/I RT) ratios in glaucoma patients. This OCT-3 metric effectively identifies structural damage, aiding early glaucoma diagnosis.
Area of Science:
- Ophthalmology
- Medical Imaging
- Glaucoma Research
Background:
- Glaucoma is a progressive optic neuropathy characterized by visual field defects.
- Accurate structural assessment is crucial for early glaucoma detection and management.
- Optical coherence tomography (OCT) provides high-resolution cross-sectional imaging of the retina.
Purpose of the Study:
- To evaluate macular retinal thickness in normal, early, and advanced glaucoma using OCT-3.
- To correlate the superior-to-inferior retinal thickness (S/I RT) ratio with visual field defects.
- To assess the utility of S/I RT ratio in diagnosing glaucoma.
Main Methods:
- A cross-sectional study involving 40 normal eyes, 40 early glaucoma eyes, and 33 advanced glaucoma eyes.
- OCT-3 imaging was performed to scan a 3x3 mm area temporal to the fovea.
- Superior-to-inferior retinal thickness (S/I RT) ratios were computed and compared between groups using ANOVA.
Main Results:
- Retinal thickness varied progressively temporal to the fovea.
- Statistically significant differences in S/I RT ratios were observed in early and advanced glaucoma eyes compared to normal eyes (P<0.05).
- These differences correlated with corresponding visual field defects.
Conclusions:
- OCT-3 derived S/I RT ratios effectively reflect structural damage in glaucoma.
- The S/I RT ratio can complement optic disc imaging for early glaucoma diagnosis.
- This imaging biomarker shows promise for enhancing glaucoma detection protocols.

